CORC

在结果中检索

CORC

浏览/检索结果: 共21条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
Effects of 919 syrup and D101 on immobilization stress response in postpartum mice 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 卷号: 12, 期号: 1
作者:  Chen, Manman;  Zhang, Lan;  Pan, Danqing;  Xu, Yuemei;  Qiu, Junxin
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma : a multicentre, single-arm, phase 2 trial 期刊论文
The Lancet Haematology, 2019, 卷号: Vol.6 No.1, 页码: e12-e19
作者:  Yuankai Shi;  Hang Su;  Yongping Song;  Wenqi Jiang;  Xiuhua Sun
收藏  |  浏览/下载：39/0  |  提交时间：2019/02/25
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
2019, 卷号: 6, 期号: 1, 页码: E12-E19
作者:  Shi, Yuankai;  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua
收藏  |  浏览/下载：19/0  |  提交时间：2020/01/03
Circulating tumor DNA to predict response and resistance by anti-PD-1 therapy in Chinese relapsed/refractory classic Hodgkin lymphoma. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31
Sintilimab for relapsed/refractory classical Hodgkin's lymphoma: Extended follow-up on the multicenter, single-arm phase II ORIENT-1 study. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Su, Hang;  Song, Yongping;  Jiang, Wenqi;  Sun, Xiuhua;  Qian, Wenbin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/31
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10
作者:  Liu, Peng;  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文
Journal of Hematology & Oncology, 2017, 卷号: 10, 期号: 1, 页码: 69-
作者:  Shi, Yuankai*;  Jia, Bo;  Xu, Wei;  Li, Wenyu;  Liu, Ting
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China. 期刊论文
Journal Of Hematology & Oncology, 2017, 卷号: Vol.10 No.1, 页码: 69
作者:  Shi Y;  Jia B;  Xu W;  Li W;  Liu T
收藏  |  浏览/下载：14/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace